Glycogenesis Type II
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Late-Onset Treatment Study Extension Protocol (NCT00455195) | Genzyme, a Sanofi Company | 2007-03-01 |
Track Glycogenesis Type II automatically
Every clearance here is in the API, with alerts when new ones post.